Novel inflammatory biomarkers associated with stroke severity: results from a cross-sectional stroke cohort study.

ABSTRACT:

Background

Stroke is a leading cause of mortality and disability worldwide and its occurrence is expected to increase in the future. Blood biomarkers have proven their usefulness in identification and monitoring of the disease. Stroke severity is a major factor for estimation of prognosis and risk of recurrent events, but knowledge on respective blood biomarkers is still scarce. Stroke pathophysiology comprises a multitude of ischemia-induced inflammatory and immune mediated responses. Therefore, the assessment of an immune-related panel in correlation with stroke severity seems promising.

Methods

In the present cross-sectional evaluation, a set of 92 blood biomarkers of a standardized immune panel were gathered (median 4.6 days after admission) and related to stroke severit

SUBMITTER: Braadt L 

PROVIDER: S-EPMC10357843 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature